Literature DB >> 11371482

Amniotic membrane transplantation in the management of conjunctival malignant melanoma and primary acquired melanosis with atypia.

D Paridaens1, H Beekhuis, W van Den Bosch, L Remeyer, G Melles.   

Abstract

AIM: To evaluate the efficacy of amniotic membrane transplantation (AMT) for the management of conjunctival malignant melanoma and primary acquired melanosis (PAM) with atypia.
METHODS: Four consecutive patients with histologically proved invasive, primary conjunctival malignant melanoma were treated with wide surgical excision and AMT. Amniotic membrane grafts were harvested and processed under sterile conditions according to a standard protocol. The grafts were sutured to the margins of the surface defect. In one case, AMT was combined with a corneoscleral graft.
RESULTS: A satisfactory result and rapid postoperative recovery with few, transient side effects was noted in three patients with limbal/epibulbar melanomas. In another patient with an extensive lesion, involving the epibulbar, forniceal, and palpebral conjunctiva, AMT following wide excision was complicated by symblepharon formation and restricted ocular motility. Monitoring of local recurrence was facilitated by the transparency of the thin graft in all cases. The postoperative follow up time varied between several months and 3 years. In one case, local recurrence of PAM was observed and treated using topical mitomycin.
CONCLUSIONS: AMT is a useful technique for the reconstruction of both small and large surface defects that result from the surgical excision of conjunctival malignant melanoma and PAM. This method facilitates wide conjunctivectomy, although its role in repairing larger defects involving the fornix or palpebral conjunctiva still needs to be established. The transparency of amniotic membrane allows for monitoring of tumour recurrence, which is-together with superior cosmesis-an advantage over thicker (for example, buccal) mucous membrane grafts.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11371482      PMCID: PMC1723999          DOI: 10.1136/bjo.85.6.658

Source DB:  PubMed          Journal:  Br J Ophthalmol        ISSN: 0007-1161            Impact factor:   4.638


  9 in total

Review 1.  Amniotic membrane transplantation.

Authors:  H S Dua; A Azuara-Blanco
Journal:  Br J Ophthalmol       Date:  1999-06       Impact factor: 4.638

2.  Multifocal amelanotic conjunctival melanoma and acquired melanosis sine pigmento.

Authors:  A D Paridaens; A C McCartney; J L Hungerford
Journal:  Br J Ophthalmol       Date:  1992-03       Impact factor: 4.638

Review 3.  Conjunctival melanoma.

Authors:  S Seregard
Journal:  Surv Ophthalmol       Date:  1998 Jan-Feb       Impact factor: 6.048

4.  Comparison of conjunctival autografts, amniotic membrane grafts, and primary closure for pterygium excision.

Authors:  P Prabhasawat; K Barton; G Burkett; S C Tseng
Journal:  Ophthalmology       Date:  1997-06       Impact factor: 12.079

5.  Topical mitomycin chemotherapy for conjunctival malignant melanoma and primary acquired melanosis with atypia: clinical experience with histopathologic observations.

Authors:  H Demirci; S A McCormick; P T Finger
Journal:  Arch Ophthalmol       Date:  2000-07

6.  Amniotic membrane transplantation for ocular surface reconstruction.

Authors:  A Azuara-Blanco; C T Pillai; H S Dua
Journal:  Br J Ophthalmol       Date:  1999-04       Impact factor: 4.638

7.  Amniotic membrane transplantation for persistent epithelial defects with ulceration.

Authors:  S H Lee; S C Tseng
Journal:  Am J Ophthalmol       Date:  1997-03       Impact factor: 5.258

8.  Amniotic membrane transplantation for conjunctival surface reconstruction.

Authors:  S C Tseng; P Prabhasawat; S H Lee
Journal:  Am J Ophthalmol       Date:  1997-12       Impact factor: 5.258

9.  Orbital exenteration in 95 cases of primary conjunctival malignant melanoma.

Authors:  A D Paridaens; A C McCartney; D C Minassian; J L Hungerford
Journal:  Br J Ophthalmol       Date:  1994-07       Impact factor: 4.638

  9 in total
  21 in total

1.  [Differential diagnosis and treatment options for conjunctival tumors].

Authors:  L M Holbach; P Pogorelov; F E Kruse
Journal:  Ophthalmologe       Date:  2007-06       Impact factor: 1.059

2.  Fresh frozen amniotic membrane for conjunctival reconstruction after excision of neoplastic and presumed neoplastic conjunctival lesions.

Authors:  U Agraval; P Rundle; I G Rennie; S Salvi
Journal:  Eye (Lond)       Date:  2017-02-17       Impact factor: 3.775

3.  Primary acquired melanosis of the conjunctiva: experience with 311 eyes.

Authors:  Jerry A Shields; Carol L Shields; Arman Mashayekhi; Brian P Marr; Raquel Benavides; Archana Thangappan; Laura Phan; Ralph C Eagle
Journal:  Trans Am Ophthalmol Soc       Date:  2007

Review 4.  Amniotic membrane transplantation in the human eye.

Authors:  Daniel Meller; Mikk Pauklin; Henning Thomasen; Henrike Westekemper; Klaus-Peter Steuhl
Journal:  Dtsch Arztebl Int       Date:  2011-04-08       Impact factor: 5.594

5.  Sutureless amniotic membrane transplantation following excision of ocular surface neoplasia.

Authors:  Altan Ozcan; Ebru Esen; Emine Ciloglu
Journal:  Int J Ophthalmol       Date:  2015-06-18       Impact factor: 1.779

6.  Management of conjunctival malignant melanoma: a review and update.

Authors:  James R Wong; Afshan A Nanji; Anat Galor; Carol L Karp
Journal:  Expert Rev Ophthalmol       Date:  2014-06

7.  Amniotic membrane transplantation for reconstruction after excision of large ocular surface neoplasias.

Authors:  E M Espana; P Prabhasawat; M Grueterich; A Solomon; S C G Tseng
Journal:  Br J Ophthalmol       Date:  2002-06       Impact factor: 4.638

8.  Proton radiotherapy as an alternative to exenteration in the management of extended conjunctival melanoma.

Authors:  Henrike Wuestemeyer; Wolfgang Sauerwein; Daniel Meller; Pierre Chauvel; Andreas Schueler; Klaus-Peter Steuhl; Norbert Bornfeld; Gerasimos Anastassiou
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2005-08-23       Impact factor: 3.117

Review 9.  Conjunctival melanoma and melanocytic intra-epithelial neoplasia.

Authors:  N Kenawy; S L Lake; S E Coupland; B E Damato
Journal:  Eye (Lond)       Date:  2012-12-07       Impact factor: 3.775

10.  Excision with corneoscleral lamellar keratoplasty and amniotic membrane transplantation of a corneal displaced recurrent conjunctival melanoma.

Authors:  Eun Chul Kim; Man Soo Kim; Nam Yeo Kang
Journal:  Korean J Ophthalmol       Date:  2012-09-24
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.